10% owner Accelmed Partners acquires 230,573 shares of SSKN at $3.14; 2 other insiders also bought in 14-day cluster amid -41.8% 90-day decline
Accelmed Partners, a 10% owner, purchased 230,573 shares at $3.14 on 2024-07-15, expanding holdings by 19.0% to 1,441,835 shares total. The timing coincides with a cluster pattern: 2 other insiders also bought within the past 14 days. This coordinated accumulation occurred as SSKN's stock has declined 41.8% over the past 90 days and 69.0% from its 52-week high of $10.00, creating a contrarian signal. The company is unprofitable (net income of -$3,368,000 in the latest quarter, negative full-year results) and experiencing revenue headwinds (-7.8% annual growth), so the cluster buy against weak fundamentals and steep price declines warrants investor scrutiny of the insiders' informational advantage or strategic positioning.